LBA54 Randomized phase III trial of nivolumab in combination with carboplatin, paclitaxel, and bevacizumab as first-line treatment for patients with advanced or recurrent non-squamous NSCLC

JS Lee, Kazuhiko Nakagawa, Jin Hyoung Kang et al.|Annals of Oncology|2020

Cited by 14